Impact of highly active antiretroviral therapy (HAART) on AIDS and death in a cohort of vertically HIV type 1-infected children: 1980-2006

AIDS Research and Human Retroviruses

Volumn 25, Issue 11, 2009, Pages 1091-1097

  Palladino, Claudia ^a,b   Bellón, Jose M ^a   Jarrín, Inmaculada ^c   Gurbindo, Maria Dolores ^d,e   De José, M Isabel ^f   Ramos, José T ^g   González Iome, M Isabel ^h   Mellado, Maria José ^f   Beceiro, José ⁱ   Amo, Julia Del ^c   Muñoz Fernández, M Ángeles ^a,e  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c CARLOS III INSTITUTE OF HEALTH   (Spain)

^d HOSPITAL MATERNO INFANTIL GREGORIO MARAÑÓN   (Spain)

^e CSIC   (Spain)

^f HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^g HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

^h HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

ⁱ HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; ATTRIBUTABLE RISK; BLOOD TRANSFUSION; CD4+ T LYMPHOCYTE; CHILD; CHILD DEATH; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; FEMALE; FOLLOW UP; GENDER; HAZARD RATIO; HETEROSEXUAL FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INCIDENCE; INFECTION RATE; INFECTION RISK; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MOTHER CHILD RELATION; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK REDUCTION; SCHOOL CHILD; VERTICAL TRANSMISSION; VIRUS LOAD; VIRUS TRANSMISSION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DRUG THERAPY, COMBINATION; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INCIDENCE; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; SPAIN; TIME FACTORS; TREATMENT OUTCOME; VIRAL LOAD;

EID: 71949129579     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2009.0070     Document Type: Article

References (25)

1. Pizzo P, Eddy J, Falloon J, et al.: Effect of continuous intravenous infusion of zidovudine (AZT) in children with symptomatic HIV infection. N Engl J Med 1988;319:889-896.
2. Teglas JP, Mayaux MJ, and Blanche S: Antiretroviral therapy and mortality among children with perinatal HIV infection. JAMA 2000;284:2871-2872.
3. Fraaij PL, Verweel G, van Rossum AM, et al.: Sustained viral suppression and immune recovery in HIV type 1-infected children after 4 years of highly active antiretroviral therapy. Clin Infect Dis 2005;40:604-608.
4. Gibb DM, Duong T, Tookey PA, et al.: Decline in mortality, AIDS, and hospital admissions in perinatally HIV-1 infected children in the United Kingdom and Ireland. BMJ 2003; 327:1019.
5. de Martino M, Tovo PA, Balducci M, et al.: Reduction in mortality with availability of antiretroviral therapy for children with perinatal HIV-1 infection. Italian Register for HIV Infection in Children and the Italian National AIDS Registry. JAMA 2000;284:190-197.
6. Gortmaker SL, Hughes M, Cervia J, et al.: Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1. N Engl J Med 2001;345:1522-1528.
7. Sanchez JM, Ramos Amador JT, Fernandez de Miguel S, et al.: Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus-infected children. Pediatr Infect Dis J 2003; 22:863-867.
8. McConnell MS, Byers RH, Frederick T, et al.: Trends in antiretroviral therapy use and survival rates for a large cohort of HIV-infected children and adolescents in the United States, 1989-2001. J Acquir Immune Defic Syndr 2005; 38:488-494.
9. Patel K, Hernan MA, Williams PL, et al.: Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: A 10-year follow-up study. Clin Infect Dis 2008;46:507-515. (Pubitemid 351263487)
10. Centro Nacional de Epidemiolog?́a, Instituto de Salud Carlos III: Vigilancia epidemioló gica del SIDA en Españ a. Actualizacio ́n a 31 de Diciembre de 2007. Informe Semestral no. 2, Añ o 2007.
11. Palladino C, Bellon JM, Perez-Hoyos S, et al.: Spatial pattern of HIV-1 mother-to-child-transmission in Madrid (Spain) from 1980 till now: Demographic and socioeconomic factors. AIDS 2008;22:2199-2205.
12. Secretaŕa del Plan Nacional sobre el SIDA: Encuesta hospitalaria sobre la utilización de recursos y caracter?́sticas de los pacientes VIH=SIDA. Noviembre 1998. Ministerio de sanidad y Consumo. www.msc.es=sida=epidemiologia.
13. Resino S, Resino R, Bellon JM, et al.: Clinical outcomes improve with highly active antiretroviral therapy in vertically HIV type-1-infected children. Clin Infect Dis 2006;43:243-252.
14. European Collaborative Study: Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy. Clin Infect Dis 2005;40:458-465.
15. Centers for Disease Control and Prevention (CDC): Guidelines for use of antiretroviral agents in pediatric HIV infection. MMWR Morb Mortal Wkly Rep 1998;47:1-43.
16. Resino S, Alvaro-Meca A, de Jose MI, et al.: Low immunologic response to highly active antiretroviral therapy in naive vertically human immunodeficiency virus type 1- infected children with severe immunodeficiency. Pediatr Infect Dis J 2006;25:365-368.
17. Centers for Disease Control and Prevention (CDC): Revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR CDC Surveill Summ 1994;43:1-10. http:==www.cdc.gov=mmwr=preview= mmwrhtml=00032890.htm.
18. Centers for Disease Control and Prevention (CDC): Revised classification system for HIV-1 infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 1992;41(RR-17):1-19.
19. Clayton C and Hills M: Statistical Models in Epidemiology. Oxford University Press, New York, 1993.
20. Natural history of vertically acquired human immunodeficiency virus-1 infection. The European Collaborative Study. Pediatrics 1994;94:815-819.
21. Marinda E, Humphrey JH, Iliff PJ, et al.: Child mortality according to maternal and infant HIV status in Zimbabwe. Pediatr Infect Dis J 2007;26:519-526.
22. Brahmbhatt H, Kigozi G, Wabwire-Mangen F, et al.: Mortality in HIV-infected and uninfected children of HIVinfected and uninfected mothers in rural Uganda. J Acquir Immune Defic Syndr 2006;41:504-508.
23. Butler KM, Husson RN, Balis FM, et al.: Dideoxyinosine in children with symptomatic human immunodeficiency virus infection. N Engl J Med 1991;324:137-144.
24. McKinney RE Jr, Maha MA, Connor EM, et al.: A multicenter trial of oral zidovudine in children with advanced human immunodeficiency virus disease. The Protocol 043 Study Group. N Engl J Med 1991;324:1018-1025.
25. Englund JA, Baker CJ, Raskino C, et al.: Zidovudine, didanosine, or both as the initial treatment for symptomatic HIVinfected children. AIDS Clinical Trials Group (ACTG) Study 152 Team. N Engl J Med 1997;336:1704-1712.